Dark

Check out our Level2View

DYNS
Dynamics Special Purpose Corp. Class A Common Stock
stock NASDAQ

Inactive

Jun 8, 2022

7.51USD-6.125%(-0.49)92,114

Pre-market

0.00USD-100.000%(-8.00)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 6, 2022

08:02AM EST Senti Biosciences, Inc. (Senti Bio), a leading Gene Circuit company today announced that Tim Lu, MD, PhD, Chief Executive Officer and Co-Founder, will present a corporate overview at the 40thAnnualJ.P. Morgan Virtual Healthcare Conference onTuesday, January 11, 2022 at2:00 p.m. EST. GlobeNewswire Inc

Dec 20, 2021

02:43PM EST Synthetic Biology Platform Senti Bio Rides On Omid Farokhzad's SPAC For NASDAQ Debut Benzinga

07:13AM EST SPAC Dynamics Special Purpose to Acquire Senti Bio, A Gene Circuit-Engineered Cell Company Benzinga

07:05AM EST - Business combination with Dynamics Special Purpose Corp. (Nasdaq: DYNS) is expected to provide more than $296 million in gross proceeds, over $153 million of which is fully committed in a common stock Private Investment in Public Equity (PIPE) financing and from non-redemption agreements - GlobeNewswire Inc

May 28, 2021

04:00PM EDT Dynamics Special Purpose Corp. Announces Closing of $230 Million Initial Public Offering Including Full Exercise of Underwriters' Over-Allotment Option Business Wire

May 26, 2021

11:26AM EDT Dynamics Shares Open For Trade At $10; IPO Priced $10/Share Benzinga

10:27AM EDT Dynamics Shares Indicating $10/Share Benzinga

09:46AM EDT Dynamics Special Purpose Corp. Shares Will Open For Quote At 10:10 a.m. EDT, Expected To Open For Trade After 10:20 a.m. EDT; IPO Priced $10/Share Benzinga

May 25, 2021

06:34PM EDT Dynamics Special Purpose Corp. Announces Pricing of $200 Million Initial Public Offering Business Wire

Share